Individualized Cancer Therapy Demonstrates Safety and Sustained Immune Responses
A study led by researchers at Mass General Brigham has found that an individualized cancer therapy tailored to the unique tumor profiles of patients with melanoma and lung cancer was well-tolerated and boosted immune activity.